Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening

被引：1
|
作者：
Carlsson, Sigrid, V [1 ,2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[3] Univ Gothenburg, Inst Clin Sci, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Prostate cancer; Prostate specific antigen; Screening; Magnetic resonance imaging; Early detection;
D O I：
10.1016/j.urolonc.2022.04.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [31] Unintended consequences of decreased PSA-based prostate cancer screening (vol 37, pg 489, 2019)
    Ahlering, Thomas
    Huynh, Linda My
    Kaler, Kamaljot S.
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John W.
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac Yi
    Porter, James
    Hu, Jim C.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 807 - 807
  • [32] PSA-based screening. Boon or bane?
    Esch, L.
    Arsov, C.
    Albers, P.
    ONKOLOGE, 2013, 19 (09): : 705 - +
  • [33] Emerging PSA-Based Tests to Improve Screening
    Bryant, Richard J.
    Lilja, Hans
    UROLOGIC CLINICS OF NORTH AMERICA, 2014, 41 (02) : 267 - +
  • [34] Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence
    Carter, H. Ballentine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1866 - 1868
  • [35] Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China
    Xu, Libo
    Wang, Jinguo
    Guo, Baofeng
    Zhang, Haixia
    Wang, Kaichen
    Wang, Ding
    Dai, Chang
    Zhang, Ling
    Zhao, Xuejian
    ONCOTARGET, 2018, 9 (01) : 428 - 441
  • [36] Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial
    Martin, Richard M.
    Donovan, Jenny L.
    Turner, Emma L.
    Metcalfe, Chris
    Young, Grace J.
    Walsh, Eleanor I.
    Lane, J. Athene
    Noble, Sian
    Oliver, Steven E.
    Evans, Simon
    Sterne, Jonathan A. C.
    Holding, Peter
    Ben-Shlomo, Yoav
    Brindle, Peter
    Williams, Naomi J.
    Hill, Elizabeth M.
    Ng, Siaw Yein
    Toole, Jessica
    Tazewell, Marta K.
    Hughes, Laura J.
    Davies, Charlotte F.
    Thorn, Joanna C.
    Down, Elizabeth
    Smith, George Davey
    Neal, David E.
    Hamdy, Freddie C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (09): : 883 - 895
  • [37] Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening
    Oliver, SE
    Holly, J
    Peters, TJ
    Donovan, J
    Persad, R
    Gillatt, D
    Pearce, A
    Hamdy, FC
    Neal, DE
    Gunnell, D
    UROLOGY, 2004, 64 (02) : 317 - 322
  • [38] PSA IN POPULATION BASED SCREENING FOR PROSTATE CANCER
    Semjonow, A.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6844 - 6845
  • [39] Lifetime benefits and harms of PSA-based risk screening for prostate cancer (vol 112, djaa001, 2020)
    Heijnsdijk, Eveline A. M.
    Gulati, Roman
    Tsodikov, Alex
    Lange, Jane M.
    Mariotto, Angela B.
    Vickers, Andrew J.
    Carlsson, Sigrid V.
    Etzioni, Ruth
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (06): : 655 - 655
  • [40] Morphologic changes in prostate cancer samples following intraprostatic PSA-Based vaccine administration
    Val, D.
    Gulley, J. L.
    Pinto, P.
    Schlom, J.
    Linehan, W. M.
    Merino, M. J.
    MODERN PATHOLOGY, 2007, 20 : 181A - 181A
12345